The Two Types of Biological Age Tests: Methylation Clocks vs Immune Aging Clocks Explained

Biological age tests fall into two broad categories: methylation-based epigenetic clocks, which read chemical modifications on DNA to estimate how fast your cells have aged, and immune aging clocks, which measure the active inflammatory biology driving that aging process right now. Understanding what each type actually measures, and what it cannot, is the most important step before choosing a test.

This article answers the questions people most commonly ask when comparing these two approaches. For a broader overview of how biological age testing works, see Biological Age Testing: The Complete Guide to Measuring How Fast You're Actually Aging.

What is a methylation clock, and how does it measure biological age?

A methylation clock is a statistical model that estimates biological age by reading DNA methylation patterns — chemical tags on the cytosine bases of your DNA that accumulate and shift across a lifetime. These clocks apply a machine-learning algorithm to hundreds of thousands of methylation sites measured from a blood or saliva sample, producing a single age estimate. Research applying the epigenetic clock to around 24,000 individuals found that population-level prediction of chronological age achieved a median error of 1.7 years, though accuracy at the individual level is considerably more variable. The most predictive methylation clock developed to date, GrimAge, is designed around biological outcomes rather than calendar age: rather than estimating how old your DNA looks, it predicts mortality and healthspan risk from methylation patterns statistically linked to plasma protein levels.

What is an immune aging clock, and how is it different?

An immune aging clock measures biological age through the lens of the immune system, specifically through glycans, which are complex sugars attached to Immunoglobulin G (IgG) antibodies in the blood. Each IgG molecule carries glycans that directly regulate whether it behaves in a pro- or anti-inflammatory way. There are around 30 different glycan structures associated with IgG, and levels of individual glycans shift measurably in numerous diseases, highlighting their potential as biomarkers of immune status. GlycanAge uses these glycan structures to calculate a biological age score that reflects the current state of chronic inflammation in the body. Both the GlycanAge glycan clock and Prof. Horvath's pan-tissue methylation clock were first published in 2013, reflecting parallel but distinct approaches to the same fundamental question. Where methylation clocks read historical patterns of gene expression, IgG glycosylation captures the active inflammatory biology that is driving aging at the moment of measurement. It is the difference between a record of where you have been and a reading of where you are now.

"Glycans on IgG are not only biomarkers that tell you what is going on — they are functional effectors that contribute to the progression of low-grade chronic inflammation. In many inflammatory diseases, IgG glycans change up to a decade before people get diagnosed with the disease."

— Prof. Gordan Lauc, Co-Founder and CSO, GlycanAge

Do methylation clocks and immune aging clocks measure the same thing?

No. These two clock types measure different biological processes, and the research community is explicit that no single biomarker captures the full picture of aging. Prof. Riccardo Marioni of the University of Edinburgh, whose team has run GrimAge and GlycanAge in parallel in the same individuals, addresses the question directly:

"I think it would be particularly valuable to measure glycans, proteins, and methylation in large cohorts on the same individuals, so we can look to see whether there are additive contributions — which I suspect there will be — and for which diseases each omics platform gives us the best information."

— Prof. Riccardo Marioni, University of Edinburgh, GlycanAge Longevity Symposium

Methylation clocks reflect epigenetic modifications tied to developmental processes and long-term gene expression history. Immune aging clocks like GlycanAge measure chronic inflammation, which the scientific literature calls inflammaging, the sustained, low-grade immune activation that accumulates with age and underlies most age-related disease. Aging is multifaceted, and different clocks illuminate different dimensions of it.

How reliable are methylation clocks for tracking whether a lifestyle intervention is working?

Methylation clocks correlate with lifestyle factors, but their sensitivity to intervention is limited and inconsistent, particularly when measured from blood. Research comparing GrimAge and GlycanAge acceleration in the same individuals has found only a small correlation between the two measures: a five-year biological acceleration on GrimAge does not necessarily correspond to a five-year acceleration on GlycanAge, and vice versa. This divergence reflects the fact that each clock is measuring a genuinely different biological layer. Different methylation clocks also vary considerably in their predictive accuracy, and because lifestyle factors affect certain clocks but not others, a change between two methylation tests may reflect which specific clock was used rather than any real biological shift. For menopausal hormone therapy specifically, blood methylation showed no measurable benefit in published research even when methylation in buccal epithelial cells did show a rejuvenating effect. This is a tissue-specificity problem meaning blood-based methylation may not register a real biological improvement even when one has occurred.

How does GlycanAge respond to lifestyle and medical interventions compared to methylation clocks?

GlycanAge's responsiveness to lifestyle and medical interventions is grounded in what glycans measure: IgG glycosylation sits at the interface between genetics and environment, integrating the effects of diet, exercise, stress, hormones, and medical treatment into a single measurable inflammatory signal.

The expected timeframe for seeing changes in GlycanAge results depends on the type of intervention. For pharmaceutical or hormonal interventions such as HRT, changes in immune balance and glycan composition can already be observed within 3–4 months, allowing early assessment of whether a protocol is working. For lifestyle-based interventions, such as diet, exercise, stress management, sleep, glycan shifts occur more gradually, typically requiring 6–12 months to show measurable improvements.

Where methylation clocks show weak or conflicting intervention signals in blood, GlycanAge captures the inflammatory biology that interventions most directly modify. For clinicians using GlycanAge to monitor HRT titration or lifestyle programmes, this responsiveness is what makes the biomarker clinically actionable rather than merely descriptive. For more on how GlycanAge integrates with clinical practice, see GlycanAge for Healthcare Providers.

Are methylation clocks accurate enough to use for repeat testing?

Methylation clocks are powerful epidemiological tools, but their repeat-measurement reliability at the individual level is a known limitation. Comparisons of multiple omics clocks in the same individuals have found that predictive accuracy varies considerably between clocks, with some tracking chronological age more closely than biological outcomes. Because lifestyle affects certain methylation clocks but not others, a change in results between two tests may reflect which specific clock was used rather than any real biological shift. For individual tracking, where the question is whether your biology has genuinely changed, measurement stability in the absence of intervention matters as much as sensitivity to change. For a broader look at how different biological age tests compare, see biological age tests compared.

What does biological age actually mean, and why does it differ from chronological age?

Chronological age counts the rotations of the planet. It is a calendar measure, as fixed and uniform as tree rings. Biological age measures how fast your body's systems are actually aging, independent of the calendar. The two diverge because aging is not uniform: the same chronological age can correspond to vastly different biological states depending on genetics, lifestyle, chronic disease burden, and cumulative inflammation. Aging is the single largest risk factor for chronic disease, which is why quantifying chronic inflammation at each life stage, rather than simply counting calendar years, is the foundation of preventive medicine. A valid biological age biomarker must correlate strongly with chronological age, predict mortality independently of age and sex, and measure a fundamental characteristic of cells. Both methylation clocks and GlycanAge meet these criteria; they differ in which biological process they use as the measurement substrate.

Which biological age test should I use: methylation or glycan?

The honest answer is that the two tests are complementary, not competing. Methylation clocks are best suited to understanding long-term epigenetic aging patterns and mortality risk stratification in epidemiological contexts. GlycanAge is best suited to measuring current immune aging and chronic inflammation, tracking whether interventions are working, and providing a stable, reproducible biological age score that changes meaningfully when health changes. If your goal is to know whether your lifestyle, HRT, supplement protocol, or clinical intervention is actually shifting your biology and to see that answer within months rather than years, GlycanAge is the more actionable choice. If you have already done a methylation clock test, GlycanAge adds the inflammatory and immune-aging layer that methylation alone cannot provide.

If you are ready to measure your immune age and track whether your health interventions are working at a biological level, order a GlycanAge test kit. Both US and European labs ensure fast turnaround times, with results typically delivered within 2–3 weeks.

Order Your GlycanAge Test Kit

External sources

• https://pmc.ncbi.nlm.nih.gov/articles/PMC8833109/ — Macdonald-Dunlop E, Taba N, Klarić L, Frkatović A, Walker R, Hayward C, Esko T, Haley C, Fischer K, Wilson JF, Joshi PK. A catalogue of omics biological ageing clocks reveals substantial commonality and associations with disease risk. Aging (Albany NY). 2022;14(2):623–659.